Differences in HPV 16- and HPV 18 E6/E7 oncogene expression between in situ and invasive adenocarcinomas of the cervix uteri

Virchows Archiv

Volumn 437, Issue 5, 2000, Pages 491-500

  Riethdorf, Sabine ^a   Riethdorf, Lutz ^a   Milde Langosch, Karin ^a   Park, Tjoung Won ^a   Löning, Thomas ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Adenocarcinoma; Adenocarcinoma in situ; Cervix uteri; HPV 16 and HPV 18 E6 E7 oncogene expression; HPV infection

Indexed keywords

ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; HISTOGENESIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IN SITU HYBRIDIZATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; UTERINE CERVIX CARCINOMA; UTERINE CERVIX CARCINOMA IN SITU; VIRUS DETECTION; WART VIRUS;

EID: 0033672873     PISSN: 09456317     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004280000277     Document Type: Article

References (53)

1. P53 retinoblastoma gene product, and cyclin protein expression in human papillomavirus DNA-positive cervical intraepithelial neoplasia and invasive cancer
2. Glandular lesions of the uterine cervix: Prognostic implications of human papillomavirus status
3. Adenocarcinoma in situ of the uterine cervix: A clinicopathologic study of 36 cases
4. Adenocarcinoma in situ of the cervix: Management and outcome
5. Adenocarcinoma in situ of the cervix: An underdiagnozed lesion
6. A new type of papillomavirus DNA, its presence in genital cancer biopsies and in cell lines derived from cervical cancer
7. Noninvasive precursor lesions of adenocarcinoma and mixed adenosquamous carcinoma of the cervix uteri
8. Immunohistochemical staining for Ki-67 antigen, carcinoembryonic antigen, and p53 in the differential diagnosis of glandular lesions of the cervix
9. The cervix
10. Polymerase chain reaction for fast, non radioactive detection of high-and low-risk papillomavirus types in routine clinical specimens and in biopsies
11. The use of general primers GP5 and GP6 elongated at their 3' ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR
12. The human papillomavirus status of 114 endocervical adenocarcinoma cases by dot blot hybridization
13. Adenocarcinoma in situ of the endocervix: Human papillomavirus determination by dot blot hybridization and polymerase chain reaction amplification
14. The human papillomavirus status of invasive cervical adenocarcinoma: A clinicopathological and outcome analysis
15. Human papillomavirus type 16 (HPV 16) gene expression and DNA replication in cervical neoplasia: Analysis by in situ hybridization
16. The human papillomavirus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product
17. Human papillomavirus messenger RNA expression in adenocarcinoma in situ of the uterine cervix
18. Analysis of human papillomavirus infection and molecular alterations in adenocarcinoma of the cervix
19. Endocervical glandular atypia. Does a preneoplastic lesion of adenocarcinoma in situ exist?
20. Demonstration of low frequency of human papillomavirus DNA in cervical adenocarcinoma and adenocarcinoma in situ by the polymerase chain reaction and in situ hybridization
21. High prevalence of human papillomavirus transcripts in all grades of cervical intraepithelial glandular neoplasia
22. Adenocarcinoma in situ of the uterine cervix progressing to invasive adenocarcinoma
23. Cervical adenocarcinoma in situ
24. Human papillomavirus DNA in uterine cervix squamous cell carcinoma and adenocarcinoma detected by polymerase chain reaction
25. The histologic diagnosis of adenocarcinoma in situ and related lesions of the cervix uteri
26. Integration of human papillomavirus type 16 DNA into the human genome leads to increased stability of E6 and E7 mRNAs: Implications for cervical carcinogenesis
27. Novel short-fragment PCR assay for highly sensitive broad-spectrum detection of anogenital human papillomaviruses
28. Telomerase activation by the E6 gene product of human papillomavirus type 16
29. Human papillomavirus E6 proteins bind p53 in vivo and abrogate p53-mediated repression of transcription
30. Low prevalence of human papillomavirus types 16 and 18 in cervical adenocarcinoma in situ, invasive adenocarcinoma and glandular dysplasia by polymerase chain reaction
31. Expression of p21waf1/cip1 in adenocarcinoma of the uterine cervix: A possible immunohistochemical marker of a favorable prognosis
32. Abnormal expression of sex steroid receptors and cell cycle-related molecules in adenocarcinoma in situ of the uterine cervix
33. Presence and persistence of HPV infection and p53 mutation in cancer of the cervix uteri and the vulva
34. Human papillomavirus type 16/18 in uterine cervical adenocarcinoma in situ and adenocarcinoma. A study by in situ hybridization with biotinylated DNA probes
35. Epidemiology of adenocarcinoma of the cervix
36. Molecular characterization of adenocarcinoma of the cervix
37. In situ and microinvasive adenocarcinoma of the uterine cervix: A clinical, cytologic and histologic study of 14 cases
38. Differential expression of the monocyte chemoattractant protein-1 gene in human papillomavirus-16-infected squamous intraepithelial lesions and squamous cell carcinomas of the cervix uteri
39. Rapid screening for Tp53 mutations by temperature-gradient gel electrophoresis: A comparison with SSCP analysis
40. Structure and transcription of human papillomavirus sequences in cervical carcinoma cells
41. Adenocarcinoma of the uterine cervix in Ireland and Sweden: Human papillomavirus infection and biologic alterations
42. Human papillomavirus type 16 and 18 gene expression in cervical neoplasias
43. Prevalence of human papillomavirus type 18 DNA in adenocarcinoma and adenosquamous carcinoma of the uterine cervix occurring in Japan
44. Human papillomavirus DNA in adenocarcinoma in situ, microinvasive adenocarcinoma of the uterine cervix, and coexisting cervical squamous intraepithelial neoplasia
45. Human papillomavirus types 16 and 18 infection in infiltrating adenocarcinoma of the cervix
46. Analysis and clinical implications of p53 gene mutations and human papillomavirus type 16 and 18 infection in primary adenocarcinoma of the uterine cervix
47. Correlation between human papillomavirus positivity and p53 gene overexpression in adenocarcinoma of the uterine cervix
48. The influence of chromosomal integration on glucocorticoid regulated transcription of the growth stimulating papillomavirus E6-E7 early genes in human cervical cancer cells
49. Human papillomavirus is a nessecary cause of invasive cervical cancer worldwide
50. Association of human papillomavirus types 16 and 18 E6 proteins with p53
51. Adenocarcinoma in situ of the cervix: Significance of cone biopsy margins
52. Alteration of cell cycle kinase complexes in human papillomavirus 16 E6- and E7-expressing fibroblasts precedes neoplastic transformation
53. Human papillomavirus DNA in adenocarcinoma and adenosquamous carcinoma of the uterine cervix detected by polymerase chain reaction